secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2024-04-15T23:59:59+00:00
Accession:  0001104659-24-047368
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals increases ATM offering to $4.85M after $1M already sold
---------------------------------------------------------------------------

- Maximum aggregate offering price raised to $4,852,909 under existing August 2023 ATM agreement with H.C. Wainwright.
- Prior to this filing, $1.0 million in common stock had been sold under the same agreement.
- Prospectus supplement filed April 15, 2024 to register the additional shares.
- No specific use of proceeds disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000110465924047368/0001104659-24-047368-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000110465924047368/tm2411778d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-047368

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer